These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21465506)

  • 1. Methodological concerns about a recent meta-analysis of the influence of the I148M variant of patatin-like phospholipase domain containing 3 on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Liu L; Shao JH; Wang K; Hua FZ
    Hepatology; 2011 Jun; 53(6):2145; author reply 2146-7. PubMed ID: 21465506
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M
    Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging genes associated with the progression of nonalcoholic fatty liver disease.
    Koutsari C; Lazaridis KN
    Hepatology; 2010 Sep; 52(3):807-10. PubMed ID: 20812353
    [No Abstract]   [Full Text] [Related]  

  • 6. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease.
    Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S
    Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
    Daly AK; Ballestri S; Carulli L; Loria P; Day CP
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population.
    Li X; Zhao Q; Wu K; Fan D
    Hepatology; 2011 Dec; 54(6):2275. PubMed ID: 21793025
    [No Abstract]   [Full Text] [Related]  

  • 9. The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine.
    Sookoian S; Pirola CJ
    Clin Liver Dis; 2012 Aug; 16(3):467-85. PubMed ID: 22824476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China.
    Li Y; Xing C; Cohen JC; Hobbs HH
    Hepatology; 2012 Jan; 55(1):327-8. PubMed ID: 21898508
    [No Abstract]   [Full Text] [Related]  

  • 11. PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?
    Dubuquoy C; Burnol AF; Moldes M
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):30-5. PubMed ID: 22884299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease.
    Browning JD; Cohen JC; Hobbs HH
    Hepatology; 2010 Oct; 52(4):1189-92. PubMed ID: 20879029
    [No Abstract]   [Full Text] [Related]  

  • 13. I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology.
    Valenti L; Alisi A; Nobili V
    Hepatology; 2012 Aug; 56(2):1883-9. PubMed ID: 23012712
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
    Chalasani N
    Gastroenterology; 2009 Sep; 137(3):772-5. PubMed ID: 19638269
    [No Abstract]   [Full Text] [Related]  

  • 15. NAFLD. PNPLA3 variant and hepatic steatosis.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2014 Aug; 11(8):455. PubMed ID: 24981722
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.
    Ballestri S; Day CP; Daly AK
    Gastroenterology; 2011 May; 140(5):1694-5. PubMed ID: 21439984
    [No Abstract]   [Full Text] [Related]  

  • 17. PNPLA3 I148M variant as a risk factor for carotid atherosclerosis in chronic hepatitis C.
    Zampino R; Florio A; Coppola N; Cirillo G; Macera M; Marrone A; Adinolfi LE; Del Giudice EM
    Int J Cardiol; 2014 Mar; 172(1):291-2. PubMed ID: 24461483
    [No Abstract]   [Full Text] [Related]  

  • 18. Common genetic variants and nonalcoholic Fatty liver disease.
    Browning JD
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1191-3. PubMed ID: 23707460
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease and the PNPLA3 gene.
    Houghton-Rahrig L; Schutte D; Fenton JI; Awad J
    Medsurg Nurs; 2014; 23(2):101-6, 121. PubMed ID: 24933787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNPLA3 I148M variant is associated with metabolic stress-response phenotype in patients with nonalcoholic fatty liver disease.
    Sookoian S; Castaño GO; Pirola CJ
    Hepatology; 2015 May; 61(5):1769. PubMed ID: 25146957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.